14-day Premium Trial Subscription Try For FreeTry Free
CEL-SCI announces change of location to 2020 Annual Meeting of Shareholders.
Several pharma & biotech companies announce their plan to fight coronavirus pandemic and state anticipated unfavorable impact of the outbreak on their business.
CEL-SCI announces the closing of its $7.7 million bought deal.
CEL-SCI increases previously announced bought deal to $7.7 million

CEL-SCI Announces Bought Deal Offering

01:46am, Tuesday, 24'th Mar 2020
CEL-SCI announces bought deal offering.
The following healthcare companies have announced actions related to the COVID-19 outbreak:Coventrus (NASDAQ:CVET): seeing strong demand for prescription management and online pharmacy services.Parall
CEL-SCI to Develop LEAPS COVID-19 Immunotherapy in Collaboration with University of Georgia Center for Vaccines and Immunology
Several pharma/companies are working to develop a treatment for novel coronavirus as WHO declares Covid-19 a pandemic.

Hot Topics Recap: Coronavirus

12:08pm, Wednesday, 11'th Mar 2020
Recap of stories on Business Wire related to Coronavirus

108 Biggest Movers From Yesterday

09:34am, Wednesday, 11'th Mar 2020
Gainers Cypress Semiconductor Corporation (NASDAQ: CY) shares jumped 48.9% to close at $22.75 on Tuesday after the company received clearance from the Committee on Foreign...
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Levi & Korsinsky announces it has commenced an investigation of CEL-SCI Corporation (NYSE:CVM) concerning possible breaches of fiduciary duty. To obtain ad
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE